文献速递血液净化与透析

美国维持性血透患者动静脉内瘘成熟全国研究

Arteriovenous Fistula Maturation in Prevalent Hemodialysis Patients in the United States: A National Study.
PubMed 文献 · Am J Kidney Dis · 2018-02-09

该研究基于美国肾脏数据系统Medicare理赔数据,纳入2013年新置动静脉内瘘的39,820例维持性血透患者,共45,087条内瘘,随访至2014年底。结果显示36.2%的内瘘无使用证据,仅54.7%在4个月内使用,成熟率因ESRD网络而异,年龄、女性、黑人、合并症等因素与成熟率降低相关。

要点

  • 36.2%的新建AVF无使用证据,仅54.7%在4个月内使用。
  • 老年、女性、黑人、心血管病等合并症和长透析龄与成熟率降低相关。
  • 不同ESRD网络间AVF成熟率差异显著,提示区域因素影响。

核心结论

  • 美国维持性血透患者中AVF成熟率不理想,且与多种患者因素相关,ESRD网络间差异提示需进一步研究提供者与区域因素。

研究设计与样本

  • 非同期观察性队列研究,基于美国肾脏数据系统Medicare理赔数据,纳入2013年新置AVF的39,820例维持性血透患者,共45,087条AVF,随访至2014年底。

主要发现

  • 36.2%的AVF无使用证据,仅54.7%在置入后4个月内使用。
  • 年龄较大与AVF成熟率降低相关。
  • 女性、黑人、心血管病、外周动脉病、糖尿病、需协助或机构化状态、透析龄>1年、ESRD发生时使用导管或移植血管与成熟率降低相关。
  • 高血压和ESRD发生时既往AVF置入与成熟率升高相关。
  • 不同ESRD网络间AVF成熟率差异显著。

临床怎么用

  • 临床应关注老年、女性、黑人及合并心血管病、糖尿病等患者AVF成熟风险,加强监测与干预。
  • 区域间成熟率差异提示需优化医疗实践与区域资源配置。

局限性

  • 研究依赖行政数据,每月记录通路使用情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Arteriovenous fistulas (AVFs) are the preferred form of hemodialysis vascular access, but maturation failures occur frequently, often resulting in prolonged catheter use. We sought to characterize AVF maturation in a national sample of prevalent hemodialysis patients in the United States. STUDY DESIGN: Nonconcurrent observational cohort study. SETTING & PARTICIPANTS: Prevalent hemodialysis patients having had at least 1 new AVF placed during 2013, as identified using Medicare claims data in the US Renal Data System. PREDICTORS: Demographics, geographic location, dialysis vintage, comorbid conditions. OUTCOMES: Successful maturation following placement defined by subsequent use identified using monthly CROWNWeb data. MEASUREMENTS: AVF maturation rates were compared across strata of predictors. Patients were followed up until the earliest evidence of death, AVF maturation, or the end of 2014. RESULTS: In the study period, 45,087 new AVFs were placed in 39,820 prevalent hemodialysis patients. No evidence of use was identified for 36.2% of AVFs. Only 54.7% of AVFs were used within 4 months of placement, with maturation rates varying considerably across end-stage renal disease (ESRD) networks. Older age was associated with lower AVF maturation rates. Female sex, black race, some comorbid conditions (cardiovascular disease, peripheral artery disease, diabetes, needing assistance, or institutionalized status), dialysis vintage longer than 1 year, and catheter or arteriovenous graft use at ESRD incidence were also associated with lower rates of successful AVF maturation. In contrast, hypertension and prior AVF placement at ESRD incidence were associated with higher rates of successful AVF maturation. LIMITATIONS: This study relies on administrative data, with monthly recording of access use. CONCLUSIONS: We identified numerous associations between AVF maturation and patient-level factors in a recent national sample of US hemodialysis patients. After accounting for these patient factors, we observed substantial differences in AVF maturation across some ESRD networks, indicating a need for additional study of the provider, practice, and regional factors that explain AVF maturation.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Woodside KJ, Bell S, Mukhopadhyay P, et al. Arteriovenous Fistula Maturation in Prevalent Hemodialysis Patients in the United States: A National Study. Am J Kidney Dis. 2018. PMID: 29429750. doi:10.1053/j.ajkd.2017.11.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。